Disease | myopathy |
Comorbidity | C0029401|paget\'s disease of the bone |
Sentences | 22 |
PubMedID- 21552523 | Recent analyses on tissues from patients suffering from inclusion body myopathy (ibm) associated with paget's disease of the bone and fronto-temporal dementia (pfd) appear to support this hypothesis [38]. |
PubMedID- 25149037 | Mutations of the valosin containing protein are instead responsible for hereditary inclusion-body myopathy with paget's disease of the bone and frontotemporal dementia (ibmpfd), with these three phenotypic features having a variable penetrance. |
PubMedID- 24348398 | Inclusion body myopathy with paget's disease of the bone and frontotemporal dementia (ibmpfd) is a rare late-onset autosomal dominant multi-system disorder, with variable penetrance of three typical clinical components: inclusion body myopathy, paget's disease and frontotemporal dementia (behavioural form). |
PubMedID- 24196964 | Single amino acid substitutions in p97 have been linked to a clinical multiple-disorder condition known as inclusion body myopathy associated with paget's disease of the bone and frontotemporal dementia. |
PubMedID- 22900631 | Background and purpose: the phenotype of ibmpfd [inclusion body myopathy with paget's disease of the bone and frontotemporal dementia (ftd)] associated with valosin-containing protein (vcp) mutation is described in three families. |
PubMedID- 20410287 | Inclusion body myopathy associated with paget's disease of the bone and fronto-temporal dementia (ibmpfd) is a progressive autosomal dominant disorder caused by mutations in p97/vcp (valosin-containing protein). |
PubMedID- 24167726 | More importantly, mutations in cdc48 have been linked directly to neurodegenerative diseases including inclusion body myopathy associated with paget's disease of the bone and frontotemporal dementia (ibmpfd) and amyotrophic lateral sclerosis (als) [85, 86, 104]. |
PubMedID- 22518139 | Mutations in p97/vcp cause inclusion body myopathy associated with paget's disease of the bone and frontotemporal dementia (ibmpfd) [107]. |
PubMedID- 21103003 | P97 has human disease relevance as it is mutated in familial cases of inclusion body myopathy associated with paget's disease of the bone and frontotemporal dementia (ibmpfd). |
PubMedID- 26112410 | Moreover, nfkb2 mrna levels were aberrantly down-regulated in patients with inclusion body myopathy associated with paget's disease of the bone and frontotemporal dementia (ibmpfd), a disease caused by mutation of p97. |
PubMedID- 23140793 | Inclusion body myopathy associated with paget's disease of the bone and frontotemporal dementia is a rare but highly penetrant autosomal dominant progressive disorder linked to mutations in valosin containing protein (vcp). |
PubMedID- 22579784 | Missense mutations that occur at the interface between two functional domains in the aaa protein p97 lead to suboptimal performance in its enzymatic activity and impaired intracellular functions, causing human disorders such as inclusion body myopathy associated with paget's disease of the bone and frontotemporal dementia (ibmpfd). |
PubMedID- 24829604 | Background: inclusion-body myopathy with paget's disease of the bone and frontotemporal dementia (ibmpfd) is a rare, late-onset autosomal disorder arising from missense mutations in a gene coding for valosin-containing protein. |
PubMedID- 23250913 | Mutations in valosin-containing protein (vcp) cause inclusion body myopathy (ibm) associated with paget's disease of the bone, fronto-temporal dementia and amyotrophic lateral sclerosis (ibmpfd/als). |
PubMedID- 25545721 | Inclusion body myopathy associated with paget's disease of the bone and frontotemporal dementia is attributed to mutations in the valosin-containing protein (vcp) gene, mapped to chromosomal region 9p13.3-12. |
PubMedID- 21222596 | Inclusion body myopathy (ibm) associated with paget's disease of the bone (pdb) and fronto-temporal dementia (ftd) or ibmpfd, is a rare multisystem degenerative disorder due to mutations in valosin containing protein (vcp). |
PubMedID- 26511028 | The same amino acid transformation as that of this patient has been reported to be involved in the pathogenesis of inclusion body myopathy with paget's disease of the bone and frontotemporal dementia. |
PubMedID- 22420316 | Vcp mutations were known to cause a rare autosomal dominant disorder with inclusion body myopathy (ibm) associated with paget's disease of the bone (pdb) and ftld, denoted as ibmpfd (105). |
PubMedID- 24707269 | Unusual clinical presentation and the age of this patient could raise the possibility of inclusion body myopathy with paget's disease of the bone and frontotemporal dementia (ibmpfd) caused by mutations in the vasolin-containing protein (vcp) gene. |
PubMedID- 25125609 | Mutations in vcp have been reported to account for a spectrum of phenotypes that include inclusion body myopathy with paget's disease of the bone and frontotemporal dementia, hereditary spastic paraplegia, and 1-2% of familial amyotrophic lateral sclerosis. |
PubMedID- 25852467 | (2013) has showed r155h (464 g>a) mutation of the vcp gene in a french family, led to the inclusion body myopathy with paget's disease of the bone and frontotemporal dementia (ibmpfd), with a psychiatric onset of ftd. |
PubMedID- 25658828 | The p97/cdc48 protein is essential for viability, but single site variants in human p97 have been linked to amyotrophic lateral sclerosis (als) [17] and to the multiple-disorder known as inclusion body myopathy associated with paget's disease of the bone and frontotemporal dementia (ibmpfd) [18] [19]. |
Page: 1